share_log

Invivyd | CORRESP: CORRESP

Invivyd | CORRESP: CORRESP

Invivyd | CORRESP:信函
美股SEC公告 ·  04/19 02:09

Moomoo AI 已提取核心訊息

Invivyd, Inc., a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on February 9, 2024. The company seeks to have the Registration Statement declared effective by 4:00 p.m. Eastern Time on April 19, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933. Invivyd's Chief Legal Officer and Corporate Secretary, Jill Andersen, signed the request, and any inquiries or communications regarding this acceleration are to be directed to Stephen M. Nicolai of Hogan Lovells US LLP.
Invivyd, Inc., a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on February 9, 2024. The company seeks to have the Registration Statement declared effective by 4:00 p.m. Eastern Time on April 19, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933. Invivyd's Chief Legal Officer and Corporate Secretary, Jill Andersen, signed the request, and any inquiries or communications regarding this acceleration are to be directed to Stephen M. Nicolai of Hogan Lovells US LLP.
生物技術公司Invivyd, Inc. 已正式要求美國證券交易委員會(SEC)加快其最初於2024年2月9日提交的S-3表格註冊聲明的生效日期。該公司希望在東部時間2024年4月19日下午4點之前宣佈註冊聲明生效。該請求是根據1933年《證券法》下的《一般規則和條例》第461條提出的。Invivyd的首席法務官兼公司秘書吉爾·安德森簽署了該請求,有關加速的任何詢問或溝通都將發送給霍根·洛弗爾斯美國律師事務所的斯蒂芬·尼古拉。
生物技術公司Invivyd, Inc. 已正式要求美國證券交易委員會(SEC)加快其最初於2024年2月9日提交的S-3表格註冊聲明的生效日期。該公司希望在東部時間2024年4月19日下午4點之前宣佈註冊聲明生效。該請求是根據1933年《證券法》下的《一般規則和條例》第461條提出的。Invivyd的首席法務官兼公司秘書吉爾·安德森簽署了該請求,有關加速的任何詢問或溝通都將發送給霍根·洛弗爾斯美國律師事務所的斯蒂芬·尼古拉。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息